35/395 184/1,753 Tau 2 = 0.00, I 2 = 0.0%, p = 0.065 Prophylaxis 26% 0.74 [0.54-1.02] 35/1,012 184/10,342 26% lower risk All studies 30% 0.70 [0.52-0.95] 37/1,035 198/10,372 30% lower risk 4 vitamin B12 COVID-19 studies c19 early .org July 2026 Tau 2 = 0.00, I 2 = 0.0%, p = 0.023 Effect extraction pre-specified (most serious outcome, see appendix) Favors vitamin B12 Favors control Download Image 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Bejan 34% 0.66 [0.30-1.44] 617 (n) 8,589 (n) Improvement, RR [CI] Treatment Control Tau 2 = 0.00, I 2 = 0.0%, p = 0.3 Prophylaxis 34% 0.66 [0.30-1.44] 617 (n) 8,589 (n) 34% lower risk All studies 34% 0.66 [0.30-1.44] 617 (n) 8,589 (n) 34% lower risk 1 vitamin B12 COVID-19 mortality result c19 early .org July 2026 Tau 2 = 0.00, I 2 = 0.0%, p = 0.3 Favors vitamin B12 Favors control Download Image 0 0.25 0.5 0.75 1 1.25 1.5 1.75 2+ Erfani (RCT) -1% 1.01 [0.72-1.41] hosp

The data products produced can be accessed via the associated repository records (Consoli et al., 2025, OpenGeoHub Foundation, 2026, while the training dataset is available via Hengl and Gupta (2025, Due to Zenodo's storage limitations and the large size of the dataset, only portions of the data are stored in Zenodo, distributed across multiple buckets
An empty stomach reduces enzymatic breakdown and may improve peptide transport across the gut lining
Effect of unilateral and simultaneous bilateral cochlear implantation on tinnitus: A Prospective Study